Abstract
Abstract
Background
Since the declaration of COVID-19 as a pandemic in 2020, its main symptoms have primarily affected the respiratory system. However, it also presents other systemic manifestations, including symptoms related to the larynx and pharynx. COVID-19 has evolved into subsequent variants, starting from the alpha variant and currently dominated by the Omicron variant, with the Delta variant being the most severe.
The study aimed to elucidate the laryngo pharyngeal manifestations related to Delta and Omicron variants of COVID-19 as well as the associated risk factors.
Results
This study adopted a case–control design. The data were collected from patients who attended the phoniatric outpatient clinic at Menoufia University Hospital from January to December 2022. Patients were categorized into three groups (50 patients each). Group I consisted of patients who exhibited COVID-19 Laryngo pharyngeal symptoms during the Delta wave (Group 1) and the Omicron wave (Group 2). The control group included non-COVID-19 participants. The symptoms related to the larynx and pharynx were documented. In addition, laryngoscopic and stroboscopic examinations were done. The age of individuals affected by the Delta variant was higher. Delta cases exhibited a higher rate of smoking, diabetes, hypertension, and COPD compared to Omicron cases. Additionally, Delta cases displayed greater severity. Dysphagia, dysphonia, choking attacks related to swallowing, and stridor had significant higher rate in the Delta variant compared to the Omicron variant. The Delta variant primarily exhibited unilateral vocal fold paralysis in 38% of cases, as well as bilateral vocal fold paresis and paralysis in 20% and 22% of cases, respectively. In contrast, Omicron cases predominantly showed vocal fold congestion (80% of cases). Delta cases were more prone to experiencing abnormalities in amplitude, symmetry, and periodicity.
Conclusions
The Delta variant is more prone to neurologic affection of the vocal folds manifesting as paresis and paralysis, whereas the Omicron variant, which has maintained its dominance thus far, experiences milder affection, primarily manifesting as congestion. Consequently, laryngeal affection with various degrees of severity is still suspected.
Publisher
Springer Science and Business Media LLC
Reference35 articles.
1. Duong BV, Larpruenrudee P, Fang T, Hossain SI, Saha SC, Gu Y, Islam MS (2022) Is the SARS CoV-2 Omicron Variant Deadlier and More Transmissible Than Delta Variant? Int J Environ Res Public Health 19(8):4586. https://doi.org/10.3390/ijerph19084586 (PMID:35457468;PMCID:PMC9032753)
2. Lovelace, Berkeley Jr (2021) "WHO says delta is becoming the dominant Covid variant globally". CNBC. Available https://www.cnbc.com/2021/06/18/who-says-delta-is-becoming-the-dominant-covid-variant-globally.html last retrieved 27 December 2023
3. Callaway E (2021) Delta coronavirus variant: scientists brace for impact. Nature. 595(7865):17–18. https://doi.org/10.1038/d41586-021-01696-3
4. Earnest R, Uddin R, Matluk N, Ranzette N et al (2021) Comparative transmissibility of SARS-CoV-2 variants Delta and Alpha in New England. USA medRxiv. https://doi.org/10.1101/2021.10.06.21264641
5. Bast E, Tang F, Dahn J et al. Increased risk of hospitalization and death with the delta variant in the USA. Lancet Infect Dis. 2021;21(12):1629–1630. https://doi.org/10.1016/S1473-3099(21)00685-X